In this episode of IBD Drive Time, Drs Millie Long and Raymond Cross, talk to Dr Sara Horst as they recap the abstract from the ECCO’23 Congress on ozanimod to help listeners understand how to utilize the drug to achieve better clinical responses in treating inflammatory bowel disease.
Raymond Cross, MD, is professor of medicine and director of the IBD Program at the University of Maryland School of Medicine in Baltimore, Maryland. Millie Long, MD, is a professor of medicine, vice chief of education and director of the fellowship program in the Division of Gastroenterology and Hepatology at the University of North Carolina at Chapel Hill. Sara Horst, MD, is an associate professor of medicine Vanderbilt University and a specialist in the treatment of IBD.
Gastroenterology Learning Network